On the other hand, Jayavelu and colleagues described, in their MPN murine model, the loss of YBX1 as a sensitization mechanism for the inhibitory capacity of JAK inhibitors (JAKi), as genetic YBX1 disruption helps diminish JAK2i-persistent cells [87]. This evidence concerns the gene YBX1 and myeloproliferative neoplasm.